Alumis

Alumis

  • Founded: 2021
  • Location: South SF, CA
  • Employee range: 11 - 50
  • Clinical stage: Clin2
  • Therapy area: Psoriasis
  • Drug types: IMM, DRM
  • Lead product: ESK-001
  • Product link: https://www.alumis.com/
  • Funding: $200M B Jan 2022; $70M A May 2021


alumis.com

linkedin.com

job board


Short description:

Autoimmune Treatments

Drug notes:

Also 3 efforts Clin0 autoimmune conditions; 2 undisclosed programs RD autoimmune conditions

Long description:

Alumis is using precision medicine to find effective treatment for patients with autoimmune disorders. Despite the advances made in treatments in the past decade, patients with autoimmune conditions continue to suffer. Using their precision analytics platform and exploration of immunologic diseases, Alumis is identifying autoimmune treatments that are right for each patient. The platform leverages high-quality curated genetic, clinical and health records data that is combined with the expertise of the Alumis team to identify the targets, pathways, indications and patient subsets they pursue. Alumis’ lead candidate, ESK-001, currently in clinical development for psoriasis with other indications soon to follow.

Jobs:

Alumis
Senior Clinical Trial Associate (Contract)
South San Francisco, California|11 days ago
Apply


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com